Circular RNA APP contributes to Alzheimer's disease pathogenesis by modulating microglial polarization via

Deng-Pan Wu1,2, Yan-Su Wei1, Li-Xiang Hou1

  • 1Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Pharmacy School, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China.

PubMed
Abstract

Insights

This study identifies circAPP, a novel circular RNA, as a key regulator in Alzheimer's disease (AD) pathogenesis. CircAPP influences microglial polarization through the miR-1906/CLIC1 pathway, offering a potential therapeutic target for AD.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Abnormal microglial polarization is implicated in Alzheimer's disease (AD) pathogenesis.
  • Circular RNAs (circRNAs) play significant roles in human diseases, with their specific functions in AD largely unexplored.

Purpose of the Study:

  • To identify and characterize novel circRNAs involved in AD pathogenesis.
  • To elucidate the functional role of circAPP in microglial polarization and AD progression.

Main Methods:

  • CircRNA microarray analysis identified differentially expressed circRNAs in AD mouse models.
  • Bioinformatics and proteomics identified circAPP targets miR-1906 and CLIC1.
  • Behavioral tests, molecular assays, and cell-based experiments assessed circAPP function in AD.

Main Results:

  • A novel circRNA, circAPP, encoded by APP, was upregulated in AD models.
  • CircAPP regulates microglial M1/M2 polarization via the miR-1906/CLIC1 axis.
  • Modulating circAPP, miR-1906, or CLIC1 improved AD pathology and cognitive function in mice.

Conclusions:

  • CircAPP plays a critical role in AD pathogenesis by regulating microglial polarization.
  • The circAPP/miR-1906/CLIC1 axis represents a potential therapeutic target for Alzheimer's disease.